Anatumomab mafenatox: Difference between revisions
Jump to navigation
Jump to search
m (Protected "Anatumomab mafenatox": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite))) |
m (Bot: Automated text replacement (-{{SIB}} + & -{{EH}} + & -{{EJ}} + & -{{Editor Help}} + & -{{Editor Join}} +)) |
||
| Line 26: | Line 26: | ||
}} | }} | ||
{{SI}} | {{SI}} | ||
==Overview== | ==Overview== | ||
| Line 32: | Line 32: | ||
{{mousemonoclonals}} | {{mousemonoclonals}} | ||
[[Category:Monoclonal antibodies]] | [[Category:Monoclonal antibodies]] | ||
[[Category:Cancer treatments]] | [[Category:Cancer treatments]] | ||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WS}} | {{WS}} | ||
Latest revision as of 22:09, 8 August 2012
Overview
Anatumomab mafenatox is a mouse monoclonal antibody which is used to treat cancers. It has a chelator, mafenatox.